Government of the United States Virgin Islands v. JPMorgan Chase Bank, N.A., No. 122-cv-10904 (S.D.N.Y. 2022)/285-48.pdf

EXHIBIT 186 Case 1:22-cv-10904-JSR Document 285-48 Filed 08/15/23 Page 1 of 4 Case 1:22-cv-10904-JSR Document 285-48 Filed 08/15/23 Page 2 of 4 From: Sent: To: susan.mickel@jpmorgan.com [susan.mickel@jpmorgan.com] 7/27/2006 8:55:34 PM mary.c.casey@jpmorgan.com Susan Mickel 212-464-1397 susan.mickel@jpmorgan.com Mail Code NY1-Nl55 --- --Forwarded by Susan X Mickel/JPMCHASE on 07 i27 /2006 04:55 PM ----- AI!I!roved New Business WA/Fiduciary Manager: Janine A. RacanelliiJPMCHASE Trust Instrument Reviewed By: Shannon Hennessey/JPMCHASE Fiduciary Mgr Handling Account: George W Kern/JPMCHASE Client/Account Names: SB II Family Trust Client/Account Code:; Redacted r\MPQ 1..--·-·-·-·-·-·-·-·-·-·· What is the status of the DDR? Date of Approval: 12/28/05 Region: Financial Markets Banker: Mary Rieth Legal Entity(s): J.P. Morgan Trust Company of Delaware Administrative Office(s): J.P. Morgan Trust Company of Delaware Source of Business: Client Refenal Current/Future/Current & Future: CwTent Account Type(s): Irrevocable (IRR) --COUNT: 1 Background Summary: Mr. Joseph Pagano is the CEO, Chairman and President of Sentigen Bio Services, a publicly traded biotechnology company. Mr. Pagano's interest in Sentigen■■■■■■■■■-Prior to this role he was a venture capitalist for 20 years. He was also the original shareholder of Office Depot. He was refened by Jeffrey Epstein, a PB client. Morgan's Role(s): JPMorgan is named co-trustee with Mark Newman. Confidential JPM-SDNYLIT-00000184_R Case 1:22-cv-10904-JSR Document 285-48 Filed 08/15/23 Page 3 of 4 Does the trust include language flermitting Morgan to deal with affiliates, waiving the duties of undivided loyalties and self- dealing'?: Yes R Funding Estimate R Compensation Estimate: ComJ)ensation: The proposed fee will be $5,000 annually with a review in three years. R Are tax costs available for inter vivos trust assets ? If not, who is the contact to obtain these? If no, then flrovide the details R Does the account hold real estate or cooperative apartment, if yes, have real estate and environmental issues been reviewed by Trust Real Estate ? If yes, then provide the details R Docs the account bold Closely Held Assets (limited partnershi11s, LLCs, LLPs, C-Corps, S-Coq1s, etc.) for which JPMorgan has investment responsibility or is otherwise directed in any capacity with respect to them? If yes, bas the Closely Held Asset Management Group a11proved the acce11tance of these assets? R Does the instrument include any investment restrictions or special investment duties '? If yes, identify article or provision and describe: ++++ R Does the account bold assets that constitute a concentrated position i.e. the position represents more than 10% of the account? If yes, please explain the situation and how it will be dealt with. Describe the specific asset, its percentage of the account and whether we are legally directed or have full investment liability. Also include the specific relevant language in the governing document that addresses the concentration or that establishes a direction by another party to hold such position. Describe concerns with environmental liability. NIA Describe concerns with closely-held securities. NIA Describe concerns with holdings of JPM securities. NIA Other Morgan business related to this client: Mr. Pagano is a new client, but it is expected that he will bring more business to us. Counsel: Firm: Kleinberg, Kaplan, Wolff & Cohen, P.C. Attorney: James Ledley Confidential JPM-SDNYLIT-00000185_R Case 1:22-cv-10904-JSR Document 285-48 Filed 08/15/23 Page 4 of 4 Locn of Instruments: File Attachments: Additional Readers: George W Kem/JPMCHASE, David A Diamond/JPMCHASE Additional Authors: George W Kern/JPMCHASE 7 App roval Section: GP/ Fiduciary Manager Ap11roval: Approved by: Janine A. Racanelli Date: 12/30/2005 11:42:41 A.J.'1 Managing Director Approval: Approved by: David A Diamond Date: 12/30/2005 11:47:41 AM Fiscal Year: 2006 'V Document History: Document History: Created by: Holly M Gyles on 12/21/2005 11:47:30 AM Revised by: Janine A. Racanelli on 30-Dec-2005 at 11 :43 :40 AM David A Diamond on 30-Dec-2005 at 11:47:45 AM Confidential JPM-SDNYLIT-00000186_ R